Iron-acrylic compound for steriotaxic aneurysm thrombosis.
A new iron-acrylic compound has been developed for stereotaxic thrombosis of intracranial aneurysms. The compound polymerizes rapidly, does not fragment, and is nontoxic. It has been used in a series of experimental animals and in initial clinical cases with good results. The use of this material simplifies and increases the safety of stereotaxic aneurysm treatment.